Mankind Pharma Ltd
NSE:MANKIND
Intrinsic Value
The intrinsic value of one MANKIND stock under the Base Case scenario is 1 686 INR. Compared to the current market price of 2 415.05 INR, Mankind Pharma Ltd is Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Mankind Pharma Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Mankind Pharma Ltd
Balance Sheet Decomposition
Mankind Pharma Ltd
Current Assets | 85.4B |
Cash & Short-Term Investments | 47.6B |
Receivables | 12.8B |
Other Current Assets | 25.1B |
Non-Current Assets | 54.5B |
Long-Term Investments | 3.6B |
PP&E | 31.4B |
Intangibles | 16.4B |
Other Non-Current Assets | 3.1B |
Free Cash Flow Analysis
Mankind Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Mankind Pharma Ltd
Revenue
|
116.4B
INR
|
Cost of Revenue
|
-33.6B
INR
|
Gross Profit
|
82.8B
INR
|
Operating Expenses
|
-58.4B
INR
|
Operating Income
|
24.4B
INR
|
Other Expenses
|
-4B
INR
|
Net Income
|
20.4B
INR
|
MANKIND Profitability Score
Profitability Due Diligence
Mankind Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Mankind Pharma Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
MANKIND Solvency Score
Solvency Due Diligence
Mankind Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Score
Mankind Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MANKIND Price Targets Summary
Mankind Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 842.3 INR with a low forecast of 2 171.5 INR and a high forecast of 3 465 INR.
Dividends
Current shareholder yield for MANKIND is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one MANKIND stock under the Base Case scenario is 1 686 INR.
Compared to the current market price of 2 415.05 INR, Mankind Pharma Ltd is Overvalued by 30%.